The AI workspace for legal professionals
- Legal research with access to more than 1 million sources
- Document automation
- Matter management
- Hosted in the EU and Switzerland
Try it free for 14 days (10 questions/day during trial)
The AI workspace for legal professionals
Try it free for 14 days (10 questions/day during trial)
17-50083•United States of America v. Washington Bryan Ii
17-50083Court of Appeals for the Ninth CircuitApr 17, 2018
NOT FOR PUBLICATION
UNITED STATES COURT OF APPEALS
FOR THE NINTH CIRCUIT
UNITED STATES OF AMERICA,
Plaintiff-Appellee,
v.
WASHINGTON BRYAN II,
Defendant-Appellant.
No. 17-50083
D.C. No.
2:16-cr-00320-RGK-1
MEMORANDUM*
Appeal from the United States District Court
for the Central District of California
R. Gary Klausner, District Judge, Presiding
Submitted April 13, 2018**
Pasadena, California
Before: ROGERS,*** BYBEE, and WATFORD, Circuit Judges.
The district court did not abuse its discretion in admitting evidence that the
structured funds were derived from a potentially illicit source. The challenged
FILED
APR 17 2018
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
* This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
** The panel unanimously concludes this case is suitable for decision
without oral argument. See Fed. R. App. P. 34(a)(2).
*** The Honorable John M. Rogers, United States Circuit Judge for the
U.S. Court of Appeals for the Sixth Circuit, sitting by designation.
-- 1 of 3 --
Page 2 of 3
evidence tended to show that Dr. Washington Bryan II prescribed opioids and
other drugs in exchange for cash. This evidence was relevant to prove that Bryan
acted with the requisite intent because it “provid[ed] a reason why [Bryan] might
have intended illegally to structure” the cash transactions. United States v. Weems,
49 F.3d 528, 532 (9th Cir. 1995). From the disputed evidence, the jury could infer
that Bryan structured his deposits to evade reporting requirements and avoid
drawing attention to his potentially improper prescription practices.
The admission of the evidence did not violate Federal Rule of Evidence 404.
Although the evidence involved acts dissimilar to the charged conduct, similarity
“is not always a prerequisite.” United States v. Ramirez-Jimenez, 967 F.2d 1321,
1326 (9th Cir. 1992). Here, the evidence was highly probative of Bryan’s motive,
and therefore was admissible under Rule 404(b). See id.
Nor did the district court abuse its discretion in weighing the risk of unfair
prejudice against the probative value of the evidence pursuant to Federal Rule of
Evidence 403. The evidence had significant probative value, particularly because
Bryan disputed the intent element at trial and offered an alternative explanation for
the pattern of deposits. While evidence of potential drug diversion carried a risk of
prejudice, the district court mitigated that risk by issuing limiting instructions to
the jury. See United States v. Flores-Blanco, 623 F.3d 912, 920 (9th Cir. 2010).
-- 2 of 3 --
Page 3 of 3
AFFIRMED.
-- 3 of 3 --
Connect Omnilex to search the legal corpus from your AI assistant.